- Home/In The News/Blog/2014/August
14
August2014
category:
503b CompoundingShortage of epilepsy drugs in Zimbabwe
HARARE, 11 August 2014 (IRIN) – Drugs for non-communicable diseases like epilepsy are being hardest hit by funding shortfalls affecting Zimbabwe’s publichealth sector. While the government is struggling to meet its budget commitments, donors are more focused on communicable diseases like HIV and TB.Tsarai Moto*, 25, from Musami village in Mashonaland East Province about 80km […]
read more14
August2014
category:
503b CompoundingBelgian pharma trade body issues recommendations on domestic drug shortages
Belgium’s pharmaceutical trade body, pharma.be, has issued a conclusion of its report on the shortage and unavailability of drugs in the Belgian market. While acknowledging that manufacturing standards often mean temporary production and supply issues, pharma.be has highlighted the free circulation of goods within the European Union as a source of drug shortages in Belgium […]
read more6
August2014
category:
503b CompoundingEnforcement Updates – Pharmaceutical & Medical Device Regulatory Update, Issue 11
Recent Product Recalls FDA announced two voluntary, company-initiated recalls. The first recall was from a compounding pharmacy recalling all nonexpired sterile drug preparations due to FDA’s concerns about the lack of sterility associated with the company’s compounding processes. The second recall, initiated by a medical packaging company, involved a recall of certain hospital dose units […]
read more